What is Kernel?
Kernel For Clinics is at the forefront of brain health innovation, developing technology that combines non-invasive brain measurements with sophisticated algorithms. This enables detailed tracking of cognitive health over time, serving both the wellness and medical markets. Their product suite includes offerings like Brain Age and cognitive trackers, alongside ongoing research aimed at improving therapeutic approaches for conditions such as depression. By equipping clinics with Kernel Scans, the company empowers healthcare professionals to achieve better patient outcomes through objective brain function data.
How much funding has Kernel raised?
Kernel has raised a total of $53M across 1 funding round:
Series C
$53M
Series C (2020): $53M with participation from Bryan Johnson, Khosla Ventures, Tiny Blue Dot, Manta Ray Ventures, Eldridge, and General Catalyst
Key Investors in Kernel
Khosla Ventures
Khosla Ventures is a venture capital firm founded in 2004, specializing in breakthrough technologies across various sectors including AI, fintech, health, and robotics. They provide venture assistance and strategic advice to entrepreneurs.
General Catalyst
General Catalyst is a venture capital firm that supports transformational business opportunities across multiple sectors and stages, focusing on backing ambitious visions and providing operational support to accelerate growth.
Bryan Johnson
An individual investor participating in Kernel's funding rounds, likely aligning with the company's mission in brain health and technology.
What's next for Kernel?
The substantial enterprise-level funding and recent strategic investment signal a period of accelerated growth and development for Kernel. This capital infusion is likely to be directed towards expanding research and development initiatives, enhancing the capabilities of their brain measurement technology, and broadening their market reach within both clinical and wellness sectors. Kernel's focus on evidence-based measurements and advanced algorithms positions them to become a leader in objective brain health assessment, potentially transforming how cognitive function is monitored and treated.
See full Kernel company page
